Skip to main content
. 2017 Aug 2;2017(8):CD001324. doi: 10.1002/14651858.CD001324.pub5
Methods Women randomly allocated to 3 groups. Method of randomisation not reported
Participants 600 women attending an urban MCH Hospital in Fuzhou, China
Excluded women attending after 72 h, irregular menstrual periods and who had had multiple acts of intercourse
Interventions Mife 150 mg vs Mife 50 mg vs Mife 25 mg, all single dose
Outcomes Observed number of pregnancies, side effects and changes in menstrual pattern
Notes
  1. Post‐randomisation exclusion or loss to follow‐up not reported

  2. Observed pregnancy/expected pregnancy/total number of women: Mife 150 mg 5/17/200; Mife 50 mg 8/15/200; Mife 25 mg 5/15/200

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Mentioned randomisation but description not adequate
Allocation concealment (selection bias) Unclear risk Method of allocation concealment not mentioned
Blinding (performance bias and detection bias) All outcomes Unclear risk Not mentioned
Incomplete outcome data (attrition bias) All outcomes Unclear risk Post‐randomisation exclusion or loss to follow‐up not reported
Selective reporting (reporting bias) Low risk Reported planned outcomes
Other bias Low risk None detected